bromine has been researched along with B16 Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aitken, JB; Austin, CJ; Harris, HH; Jolliffe, KA; Rendina, LM; Sheridan, EJ; Vogt, S | 1 |
| Glazman-Kuśnierczyk, H; Matuszyk, J; Radzikowski, C | 1 |
2 other study(ies) available for bromine and B16 Melanoma
| Article | Year |
|---|---|
Synchrotron X-ray fluorescence studies of a bromine-labelled cyclic RGD peptide interacting with individual tumor cells.
Topics: Animals; Bromine; Humans; Lung Neoplasms; Melanoma, Experimental; Mice; Neovascularization, Pathologic; Oligopeptides; Peptides, Cyclic; Spectrometry, X-Ray Emission; Tumor Cells, Cultured | 2013 |
Antitumor activity evaluation of bromine-substituted analogues of ifosfamide. I. Stereodifferentiation of biological effects and selection of the most potent compounds.
Topics: Animals; Bromine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Ifosfamide; Lethal Dose 50; Leukemia L1210; Lung Neoplasms; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasms, Experimental; Stereoisomerism; Structure-Activity Relationship | 1992 |